Security key
87164F105
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX)
CUSIP: 87164F105
Q1 2022 13F Holders as of 31 Mar 2022
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 86,328,130
- Total 13F shares
- 54,572,890
- Share change
- -1,028,787
- Total reported value
- $948,388,792
- Put/Call ratio
- 0%
- Price per share
- $17.38
- Number of holders
- 136
- Value change
- -$36,428,045
- Number of buys
- 78
- Number of sells
- 51
Report period
Q1 2022
Institutions
136
Top holders
10
SNDX full security history
Newer quarter: Q2 2022
Previous quarter: Q4 2021
Syndax Pharmaceuticals Inc SEC filings
Syndax Pharmaceuticals Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 87164F105
Recent filing periods:
Top shareholders of SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Avidity Partners Management LP |
13F
|
Company |
5.6%
|
4,823,400
|
$105,584,000 | — | 31 Dec 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.3%
|
3,689,894
|
$80,771,000 | — | 31 Dec 2021 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
3.3%
|
2,850,559
|
$62,399,000 | — | 31 Dec 2021 | |
| FRAZIER MANAGEMENT LLC |
13F
|
Company |
3.2%
|
2,772,062
|
$60,680,000 | — | 31 Dec 2021 | |
| STATE STREET CORP |
13F
|
Company |
2.9%
|
2,480,204
|
$54,292,000 | — | 31 Dec 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.7%
|
2,337,370
|
$51,165,000 | — | 31 Dec 2021 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
2.5%
|
2,175,000
|
$47,611,000 | — | 31 Dec 2021 | |
| PFM Health Sciences, LP |
13F
|
Company |
2.4%
|
2,103,512
|
$46,046,000 | — | 31 Dec 2021 | |
| BVF INC/IL |
13F
|
Company |
2.4%
|
2,099,714
|
$45,963,000 | — | 31 Dec 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.3%
|
2,018,827
|
$44,192,000 | — | 31 Dec 2021 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
2.3%
|
1,981,300
|
$43,371,000 | — | 31 Dec 2021 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.9%
|
1,598,766
|
$34,997,000 | — | 31 Dec 2021 | |
| 683 Capital Management, LLC |
13F
|
Company |
1.6%
|
1,395,492
|
$30,547,000 | — | 31 Dec 2021 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.4%
|
1,200,000
|
$26,268,000 | — | 31 Dec 2021 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
1.4%
|
1,176,585
|
$25,755,000 | — | 31 Dec 2021 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
1,165,000
|
$25,502,000 | — | 31 Dec 2021 | |
| HealthCor Management, L.P. |
13F
|
Company |
1.3%
|
1,157,560
|
$25,339,000 | — | 31 Dec 2021 | |
| Aisling Capital Management LP |
13F
|
Company |
1.2%
|
1,025,000
|
$22,437,000 | — | 31 Dec 2021 | |
| Kynam Capital Management, LP |
13F
|
Company |
1.1%
|
956,165
|
$20,930,000 | — | 31 Dec 2021 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
1.1%
|
951,226
|
$20,822,000 | — | 31 Dec 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.92%
|
793,700
|
$17,374,000 | — | 31 Dec 2021 | |
| BARCLAYS PLC |
13F
|
Company |
0.9%
|
775,476
|
$16,976,000 | — | 31 Dec 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.89%
|
764,627
|
$16,737,000 | — | 31 Dec 2021 | |
| Palo Alto Investors LP |
13F
|
Company |
0.69%
|
598,900
|
$13,110,000 | — | 31 Dec 2021 | |
| NORGES BANK |
13F
|
Company |
0.56%
|
484,900
|
$10,614,000 | — | 31 Dec 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.53%
|
453,676
|
$9,931,000 | — | 31 Dec 2021 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
0.52%
|
453,091
|
$9,918,000 | — | 31 Dec 2021 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.42%
|
363,661
|
$7,960,000 | — | 31 Dec 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.41%
|
354,552
|
$7,761,000 | — | 31 Dec 2021 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.41%
|
353,100
|
$7,729,000 | — | 31 Dec 2021 | |
| Phoenix Financial Ltd. |
13F
|
Company |
0.4%
|
342,356
|
$7,494,000 | — | 31 Dec 2021 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.37%
|
322,720
|
$7,064,000 | — | 31 Dec 2021 | |
| Woodline Partners LP |
13F
|
Company |
0.36%
|
310,377
|
$6,794,000 | — | 31 Dec 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.35%
|
305,996
|
$6,699,000 | — | 31 Dec 2021 | |
| Ghost Tree Capital, LLC |
13F
|
Company |
0.35%
|
300,000
|
$6,567,000 | — | 31 Dec 2021 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.34%
|
296,535
|
$6,491,000 | — | 31 Dec 2021 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.33%
|
288,052
|
$6,305,000 | — | 31 Dec 2021 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.33%
|
283,954
|
$6,216,000 | — | 31 Dec 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.32%
|
277,476
|
$6,074,000 | — | 31 Dec 2021 | |
| ACUTA CAPITAL PARTNERS, LLC |
13F
|
Company |
0.24%
|
206,126
|
$4,512,000 | — | 31 Dec 2021 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.23%
|
200,842
|
$4,396,000 | — | 31 Dec 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.22%
|
188,934
|
$4,135,000 | — | 31 Dec 2021 | |
| FMR LLC |
13F
|
Company |
0.22%
|
187,349
|
$4,101,000 | — | 31 Dec 2021 | |
| MACQUARIE GROUP LTD |
13F
|
Company |
0.21%
|
180,991
|
$3,962,000 | — | 31 Dec 2021 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.2%
|
175,000
|
$3,831,000 | — | 31 Dec 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.2%
|
170,473
|
$3,731,000 | — | 31 Dec 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.19%
|
166,572
|
$3,647,000 | — | 31 Dec 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.19%
|
163,861
|
$2,932,000 | — | 31 Dec 2021 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.18%
|
157,832
|
$3,455,000 | — | 31 Dec 2021 | |
| UBS Group AG |
13F
|
Company |
0.16%
|
140,517
|
$3,076,000 | — | 31 Dec 2021 |
Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q1 2022
As of 31 Mar 2022,
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) was held by
136 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
54,572,890 shares.
The largest 10 holders included
Avidity Partners Management LP, BlackRock Inc., Frazier Life Sciences Management, L.P., Nantahala Capital Management, LLC, VANGUARD GROUP INC, BVF INC/IL, STATE STREET CORP, Avoro Capital Advisors LLC, ORBIMED ADVISORS LLC, and PFM Health Sciences, LP.
This page lists
136
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2022 vs Q4 2021 Across Filers
Q4 2021 holders
129
Q1 2022 holders
136
Holder diff
7
| Investor | Q4 2021 Shares | Q1 2022 Shares | Share Diff | Share Chg % | Q4 2021 Value $ | Q1 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.